Our running hypothesis is that during the biological evolution of the leukemic CLL clones, excessive RRAS2 overexpression could lead to senescence or to a dead-end differentiation of the pre-malignant B-cell clones. This evidence concerns the gene RRAS2 and B-cell chronic lymphocytic leukemia.